Single-Center Evaluation of the Pharmacokinetics of WCK 5222 (Cefepime-Zidebactam Combination) in Subjects With Renal Impairment

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.01484-18
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

In Vivo Efficacy of Humanized WCK 5222 (Cefepime-Zidebactam) Exposures Against Carbapenem-Resistant Acinetobacter Baumannii in the Neutropenic Thigh Model

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2018English

Single-Dose Pharmacokinetics and Safety of Daclatasvir in Subjects With Renal Function Impairment

Antiviral Therapy
Infectious DiseasesPharmacology
2015English

The Pharmacokinetics and Safety of Darapladib in Subjects With Severe Renal Impairment

British Journal of Clinical Pharmacology
Pharmacology
2015English

Pharmacokinetics of Cefepime After Single and Multiple Intravenous Administrations in Healthy Subjects.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1992English

Single-Dose, Open-Label Study of the Differences in Pharmacokinetics of Colchicine in Subjects With Renal Impairment, Including End-Stage Renal Disease

Clinical Drug Investigation
MedicinePharmacology
2014English

Pharmacokinetics of the Dual Melatonin Receptor Agonist Tasimelteon in Subjects With Hepatic or Renal Impairment

Journal of Clinical Pharmacology
Pharmacology
2015English

Pharmacokinetics and Safety of Tenofovir Alafenamide in HIV-Uninfected Subjects With Severe Renal Impairment

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2016English

The Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus

Journal of Clinical Pharmacology
Pharmacology
2017English

Pharmacokinetics of Cefepime During Continuous Renal Replacement Therapy in Critically Ill Patients

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy